Pacific Biosciences of California, Inc. (PACB)
2.005
-0.12
(-5.42%)
USD |
NASDAQ |
Dec 16, 13:25
Pacific Biosciences of California Research and Development Expense (Annual): 129.02M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Intellia Therapeutics, Inc. | 456.03M |
| Celldex Therapeutics, Inc. | 160.37M |
| Atossa Therapeutics, Inc. | 14.12M |
| Abeona Therapeutics, Inc. | 34.36M |
| Kiora Pharmaceuticals, Inc. | 7.842M |